EyePoint Pharmaceuticals
EYPT
#5837
Rank
S$1.47 B
Marketcap
S$17.69
Share price
-2.81%
Change (1 day)
100.31%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -S$0.29 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are S$42.34 Million. In 2024 the company made an earning of -S$0.19 Billion a decrease over its 2023 earnings that were of -S$88.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.29 Billion54.84%
2024 -S$0.19 Billion104.29%
2023 -S$88.78 Million-29.88%
2022 -S$0.13 Billion87.2%
2021 -S$67.64 Million38.58%
2020 -S$48.81 Million-24.56%
2019 -S$64.7 Million
2017 -S$29.51 Million22.59%
2016 -S$24.07 Million-8.02%
2015 -S$26.17 Million-296.09%
2014 S$13.34 M-174.02%
2013 -S$18.03 Million37.42%
2012 -S$13.12 Million-56.29%
2011 -S$30.02 Million-1062.38%
2010 S$3.11 M-250.43%
2009 -S$2.08 Million-89.5%
2008 -S$19.75 Million
2005 -S$12.18 Million56.99%
2004 -S$7.76 Million73.7%
2003 -S$4.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-S$2.77 Million-98.99% Bahamas
NRC Health
NRC
S$35.23 M-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA